Generic of Sensipar: US court denies Amgen request for preliminary injunction against Cipla
Cipla's cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg are generic versions of Sensipar, a branded drug marketed by Amgen Inc.
New Delhi: Pharma major Cipla Friday said the US District Court of Delaware has denied Amgen Inc's request for a preliminary injunction to stop Cipla's continued sale of its generic cinacalcet hydrochloride tablets in the US market.
The preliminary injunction is a court order made in the early stages of a lawsuit that prohibits the parties from doing an act in order to preserve the status quo until the trial is over and the court has issued a ruling or judgment.
Read Also:Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension
The company had announced a phased launch of generic cinacalcet hydrochloride tablets, used in the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis, in the US market in a regulatory filing in March this year.
The launch, however, is a subject of ongoing litigation, it had added.
Read Also: Dr Reddys, Cipla arm recall drugs in US; includes 7.8 lakh vials of Testosterone Cypionate injection
"... Chief Judge Stark of the US District Court of Delaware denied Amgen, Inc's request for a preliminary injunction to stop Cipla's continued sale of its generic cinacalcet hydrochloride tablets 30mg, 60mg, 90mg in the USA," Cipla said in a filing to BSE.
Cipla's cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg are generic versions of Sensipar, a branded drug marketed by Amgen Inc.
Read Also: Cipla appoints Dr Raju Mistry as Global Chief People Officer
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd